ALBT (avalon-globocare.com) חוב לטווח קצר להון

This ALBT price chart complements data regarding the network of certified laboratories and research centers in the US with enhanced energy security. Avalon GloboCare provides cell biologists with competitive compensation and the resources necessary to develop new treatment methods. The current figure stands at 0.12, while business resilience is supported by diagnostic profitability and the successful merger of medical divisions.

This ratio reflects the company's dependence on short-term liabilities by comparing loans with a maturity of up to one year against total equity to assess liquidity and the risk of cash flow gaps. By analyzing the trend of short-term loans relative to equity, investors can evaluate the financial stability of Avalon GloboCare (ALBT), whose IT outsourcing strategy for medical treatment allows the company to optimize operating expenses and reduce its debt load.